Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 6/20 | 0.39 |
| ▸ | DPP4 | P27487 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PTPRC | P08575 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL246872 | 0.88 | ERN1 (0.45) | ERN1DPP4KDM4EALDH1A1GAA | |
| SCHEMBL5804669 | 0.78 | KDM4E (0.30) | KDM4EALDH1A1GAAMAPTHPGD | |
| SCHEMBL498579 | 0.78 | DPP4 (0.55) | ERN1DPP4KDM4EALDH1A1GAA | |
| SCHEMBL9231804 | 0.76 | ERN1 (0.49) | ERN1DPP4KDM4EALDH1A1GAA | |
| SCHEMBL10551506 | 0.74 | ERN1 (0.45) | ERN1DPP4KDM4EALDH1A1MAPT | |
| SCHEMBL10551507 | 0.73 | ERN1 (0.44) | ERN1DPP4KDM4EALDH1A1GAA | |
| SCHEMBL2783306 | 0.72 | TRPA1 (0.33) | MAPTLMNA | |
| SCHEMBL22734772 | 0.71 | PTPRC (0.41) | KDM4EALDH1A1GAAMAPTHPGD | |
| SCHEMBL22734807 | 0.71 | PTPRC (0.41) | KDM4EALDH1A1GAAMAPTHPGD | |
| SCHEMBL22763310 | 0.71 | PTPRC (0.41) | KDM4EALDH1A1GAAMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2559720-A1 | CROSSLINKED COMPOSITION | Daicel Corporation (JP) | 2013-02-20 | — | — | EP | disclosed |
| US-20130026458-A1 | CROSSLINKABLE COMPOSITION | DAICEL CORPORATION (JP) | 2013-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130026458-A1 | CROSSLINKABLE COMPOSITION | DDC, ODC1, SRM | ERN1 1867/4885DPP4 4713/4885KDM4E 901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.